Position in LLY
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$13,030,606
+$5,871,118 QoQ
Shares Held
10,864
+39.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.98%
of 13F equity value
Holder Rank
#1,115
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Simmons Bank holds $67,934,657 across 11 Drug Manufacturers - General names. LLY ranks #2 (19.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
51,844 | $13,046,023 | |
| 2 | LLY |
ELI LILLY & Co
This page
|
10,864 | $13,030,606 | |
| 3 | AMGN |
Amgen Inc
|
26,161 | $9,473,419 | |
| 4 | MRK |
Merck & Co., Inc.
|
70,419 | $9,048,841 | |
| 5 | JNJ |
Johnson & Johnson
|
35,136 | $8,923,488 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
37,464 | $4,733,201 | |
| 7 | PFE |
Pfizer Inc
|
125,117 | $3,012,817 | |
| 8 | GSK |
GSK plc
|
57,449 | $3,011,475 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $13,030,606 | 10,864 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $7,159,488 | 7,784 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $8,293,305 | 7,717 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $6,043,723 | 7,921 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $6,133,340 | 7,868 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $6,636,186 | 8,035 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $6,264,008 | 8,114 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $7,449,868 | 8,409 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $7,503,788 | 8,288 | Shares | Sole | 2024-07-26 | |
| 2024-03-31 | $6,479,627 | 8,329 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $4,670,353 | 8,012 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $4,181,555 | 7,785 | Shares | Sole | 2023-10-26 | |
| 2023-06-30 | $3,528,604 | 7,524 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $2,532,378 | 7,374 | Shares | Sole | 2023-04-28 | |
| 2022-12-31 | $1,832,490 | 5,009 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $1,605,108 | 4,964 | Shares | Sole | 2022-10-27 | |
| 2022-06-30 | $1,604,937 | 4,950 | Shares | Sole | 2022-07-29 | |
| 2022-03-31 | $1,419,822 | 4,958 | Shares | Sole | 2022-04-21 | |
| 2021-12-31 | $1,413,970 | 5,119 | Shares | Sole | 2022-01-28 | |
| 2021-09-30 | $1,246,745 | 5,396 | Shares | Sole | 2021-10-26 | |
| 2021-06-30 | $1,326,165 | 5,778 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $1,101,677 | 5,897 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $1,036,170 | 6,137 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $1,264,830 | 8,545 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $1,403,738 | 8,550 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $1,034,018 | 7,454 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||